• Insight Guru outlined a 2027 plan to cut per-procedure instrument revenue by extending allowed uses on a subset of instruments.
• Program targets high-volume benign procedures, aiming to lower customer cost per case to drive higher procedure volumes.
• Impact is expected to phase in progressively across 2027, not as a one-time reset; stapling, energy products, force feedback instruments excluded.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Guru Inc. published the original content used to generate this news brief on September 18, 2026, and is solely responsible for the information contained therein.